[{"Assets_0_Q2_USD":"38666400000.0","CIK":"59478","CommonStockDividendsPerShareDeclared_1_Q2_USD":"1.29","CommonStockDividendsPerShareDeclared_2_Q2_USD":"1.29","Country":"United States","EarningsPerShareBasic_1_Q2_USD":"1.44","EarningsPerShareBasic_2_Q2_USD":"5.86","EarningsPerShareDiluted_1_Q2_USD":"1.44","EarningsPerShareDiluted_2_Q2_USD":"5.84","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"282857000000.0","MinorityInterest_0_Q2_USD":"76800000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":"1362800000.0","NetIncomeLoss_1_Q2_USD":"1327200000.0","NetIncomeLoss_2_Q2_USD":"5568800000.0","OfficialName":"Eli Lilly and Company Common Stock","RevenuesConverted_1_Q2_USD":"5636700000.0","RevenuesConverted_2_Q2_USD":"10728900000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquityConverted_0_Q2_USD":"2857300000.0","StockholdersEquity_0_Q2_USD":"2780500000.0","Ticker":"LLY","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":"924600000.0","WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":"954200000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":"920800000.0","WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":"950400000.0","filed":"20190802","footnote":null,"form":"10-Q","fp":"Q2","fy":"2019.0","name":"LILLY ELI & CO","period":"20190630","qtrs":"0","uom":"USD"}]